The athena breast health network: Developing a rapid learning system in breast cancer prevention, screening, treatment, and care

Breast Cancer Research and Treatment

Volumn 140, Issue 2, 2013, Pages 417-425

  Elson, Sarah L ^a   Hiatt, Robert A ^a   Anton Culver, Hoda ^b   Howell, Lydia P ^c   Naeim, Arash ^d   Parker, Barbara A ^e   Van'T Veer, Laura J ^f   Hogarth, Michael ^g   Pierce, John P ^e   Duwors, Robert J ^d   Hajopoulos, Kathy ^a   Esserman, Laura J ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Learning healthcare system; Precision medicine; Transdisciplinary science

Indexed keywords

ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL PROTOCOL; DISEASE COURSE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; INFORMATION SCIENCE; LEARNING; LIFESTYLE MODIFICATION; MEDICAL INFORMATION; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; UNITED STATES; BREAST NEOPLASMS; FEMALE; INFORMATION SERVICE;

BREAST NEOPLASMS; FEMALE; HUMANS; INFORMATION SERVICES; LEARNING;

EID: 84881480910     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2612-0     Document Type: Article

References (26)

1. Ellsworth RE, Decewicz DJ, Shriver CD, Ellsworth DL (2010) Breast cancer in the personal genomics era. Curr Genomics 11(3):146-161
2. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC (2011) Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat 129(2):607-616
3. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease (2011) Toward precision medicine building a knowledge network for biomedical research and a new taxonomy of disease. The National Academies Press, Washington, DC
4. Buyse M, Loi S, van't Veer L, Viale G, Delorenzi M, Glas AM, d'Assignies MS, Bergh J, Lidereau R, Ellis P, Harris A, Bogaerts J, Therasse P, Floore A, Amakrane M, Piette F, Rutgers E, Sotiriou C, Cardoso F, Piccart MJ (2006) Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 98(17):1183-1192
5. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N (2006) Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 24(23):3726-3734
6. Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, Bach PB, Murphy SB (2010) Rapid-learning system for cancer care. J Clin Oncol 28(27):4268-4274
7. Institute of Medicine (US) and National Academy of Engineering (US) Roundtable on Value & Science-Driven Health Care (2011) Engineering a learning healthcare system: A look at the future: workshop summary. The National Academies Press, Washington DC
8. Luce BR, Kramer JM, Goodman SN, Connor JT, Tunis S, Whicher D, Schwartz JS (2009) Rethinking randomized clinical trials for comparative effectiveness research: the need for transformational change. Ann Intern Med 151(3):206-209
9. Bast RC Jr, Lilja H, Urban N, Rimm DL, Fritsche H, Gray J, Veltri R, Klee G, Allen A, Kim N, Gutman S, Rubin MA, Hruszkewycz A (2005) Translational crossroads for biomarkers. Clin Cancer Res 11(17):6103-6108
10. Hood L, Friend SH (2011) Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8(3):184-187
11. Sung NS, Crowley WF Jr, Genel M, Salber P, Sandy L, Sherwood LM, Johnson SB, Catanese V, Tilson H, Getz K, Larson EL, Scheinberg D, Reece EA, Slavkin H, Dobs A, Grebb J, Martinez RA, Korn A, Rimoin D (2003) Central challenges facing the national clinical research enterprise. JAMA 289(10):1278-1287
12. Disis ML, Slattery JT (2010) The road we must take: multidisciplinary team science. Sci Transl Med 2(22):22-29
13. Hiatt RA, Breen N (2008) The social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med 35(2 Suppl):S141-S150
14. Evans DG, Howell A (2007) Breast cancer risk-assessment models. Breast cancer research 9(5):213
15. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L (2007) Pilot trial of a computerized decision aid for breast cancer prevention. Breast J 13(2):147-154
16. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL (2012) Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 156(9):635-648
17. Walter LC, Lewis CL, Barton MB (2005) Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence. Am J Med 118(10):1078-1086
18. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K (2009) Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst 101(6):384-398
19. Patterson RE, Cadmus LA, Emond JA, Pierce JP (2010) Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature. Maturitas 66(1):5-15
20. Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS (2009) Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy. Radiology 253(3):641-651
21. Bueno-de-Mesquita JM, Nuyten DS, Wesseling J, van Tinteren H, Linn SC, van de Vijver MJ (2010) The impact of inter-observer variation in pathological assessment of node-negative breast cancer on clinical risk assessment and patient selection for adjuvant systemic treatment. Ann Oncol 21(1):40-47
22. Dowsett M, Nielsen TO, A'Hern R, Bartlett J, Coombes RC, Cuzick J, Ellis M, Henry NL, Hugh JC, Lively T, McShane L, Paik S, Penault-Llorca F, Prudkin L, Regan M, Salter J, Sotiriou C, Smith IE, Viale G, Zujewski JA, Hayes DF (2011) Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103(22):1656-1664
23. Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, Zabaglo L, Mallon E, Green AR, Ellis IO, Howell A, Buzdar AU, Forbes JF (2011) Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol 29(32):4273-4278
24. http://seer.cancer.gov/csr/1975-2009/
25. Hahn EE, Ganz PA, Melisko ME, Pierce JP, von Friederichs-Fitzwater M, Lane KT, Hiatt RA (2013) Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. doi: 10.1007/s11764-013-0269-7
26. Natarajan L, Pu M, Parker BA, Thomson CA, Caan BJ, Flatt SW, Madlensky L, Hajek RA, Al-Delaimy WK, Saquib N, Gold EB, Pierce JP (2009) Time-varying effects of prognostic factors associated with disease-free survival in breast cancer. Am J Epidemiol 169(12):1463-1470